Skip to main content
Top
Published in: Endocrine 3/2016

01-12-2016 | Original Article

Modifiable risk factors for gestational diabetes recurrence

Authors: Naama Schwartz, Manfred S. Green, Enav Yefet, Zohar Nachum

Published in: Endocrine | Issue 3/2016

Login to get access

Abstract

The literature on risk factors for gestational diabetes mellitus recurrence is inconsistent and sometimes contradictory. The importance of inter-pregnancy interval and parity, remains unclear. We aimed to explore controversial risk factors for gestational diabetes mellitus recurrence, especially the modifiable ones, and to develop a prediction model in a cohort of women with gestational diabetes mellitus. A retrospective, population-based, cross-sectional cohort study was performed. The study included 788 women with gestational diabetes mellitus that delivered between 1991–2012 and had consecutive deliveries at a university affiliated hospital in Israel. Women with pre-existing diabetes were excluded. Factors associated with gestational diabetes mellitus recurrence were examined using log-binomial models to estimate prevalence ratios with 95 % confidence intervals. Multivariate analysis revealed that both inter-pregnancy interval and multiparity were significant risk factors for gestational diabetes mellitus recurrence. Other significant risk factors were maternal age, gestational diabetes mellitus diagnosis week, oral glucose tolerance test values, body mass index gain between pregnancies and insulin use; the latter and multiparity had the strongest effect size (PR ≥ 1.2). Among multiparous women, the association between inter-pregnancy interval and gestational diabetes mellitus recurrence was significantly lower (P = 0.0004) compared with primiparous women (PR = 1.11 [95 % CI 1.09–1.13] versus PR = 1.17 [95 % CI 1.15–1.20], respectively). The model we developed, predicts that reducing the inter-pregnancy interval and weight gain between pregnancies can reduce substantially the risk of gestational diabetes mellitus recurrence. The results suggest that weight gain and inter-pregnancy interval are modifiable risk factors for gestational diabetes mellitus recurrence. Our model could assist physicians in advising women with gestational diabetes mellitus in reducing the risk of recurrent gestational diabetes mellitus during subsequent pregnancies.
Appendix
Available only for authorised users
Literature
1.
go back to reference American Diabetes Association, Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 32(Supplement_1), S62–S67 (2009)CrossRefPubMedCentral American Diabetes Association, Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 32(Supplement_1), S62–S67 (2009)CrossRefPubMedCentral
2.
go back to reference B.E. Metzger, D.R. Coustan, Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 21(Suppl 2), B161–B167 (1998)PubMed B.E. Metzger, D.R. Coustan, Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 21(Suppl 2), B161–B167 (1998)PubMed
3.
go back to reference A. Ferrara, H.S. Kahn, C.P. Quesenberry, C. Riley, M.M. Hedderson, An Increase in the Incidence of Gestational Diabetes Mellitus: Northern California, 1991–2000. Obstet Gynecol 103(3), 526–533 (2004)CrossRefPubMed A. Ferrara, H.S. Kahn, C.P. Quesenberry, C. Riley, M.M. Hedderson, An Increase in the Incidence of Gestational Diabetes Mellitus: Northern California, 1991–2000. Obstet Gynecol 103(3), 526–533 (2004)CrossRefPubMed
4.
go back to reference N.A. Beischer, J.N. Oats, O.A. Henry, M.T. Sheedy, J.E. Walstab, Incidence and Severity of Gestational Diabetes Mellitus According to Country of Birth in Women Living in Australia. Diabetes 40(Supplement_2), 35–38 (1991)CrossRefPubMed N.A. Beischer, J.N. Oats, O.A. Henry, M.T. Sheedy, J.E. Walstab, Incidence and Severity of Gestational Diabetes Mellitus According to Country of Birth in Women Living in Australia. Diabetes 40(Supplement_2), 35–38 (1991)CrossRefPubMed
5.
go back to reference B.E. Metzger, Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol 50(4), 972–979 (2007)CrossRefPubMed B.E. Metzger, Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol 50(4), 972–979 (2007)CrossRefPubMed
6.
go back to reference N. Schwartz, Z. Nachum, M.S. Green, The prevalence of gestational diabetes mellitus recurrence-effect of ethnicity and parity: a metaanalysis. Am J Obstet Gynecol 213(3), 310–317 (2015)CrossRefPubMed N. Schwartz, Z. Nachum, M.S. Green, The prevalence of gestational diabetes mellitus recurrence-effect of ethnicity and parity: a metaanalysis. Am J Obstet Gynecol 213(3), 310–317 (2015)CrossRefPubMed
7.
go back to reference J.R. Steinhart, J.R. Sugarman, F.A. Connell, Gestational diabetes is a herald of NIDDM in Navajo women. High rate of abnormal glucose tolerance after GDM. Diabetes Care 20(6), 943–947 (1997)CrossRefPubMed J.R. Steinhart, J.R. Sugarman, F.A. Connell, Gestational diabetes is a herald of NIDDM in Navajo women. High rate of abnormal glucose tolerance after GDM. Diabetes Care 20(6), 943–947 (1997)CrossRefPubMed
8.
go back to reference F. Pallardo, L. Herranz, T. Garcia-Ingelmo, C. Grande, P. Martin-Vaquero, M. Jañez, A. Gonzalez, Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care 22(7), 1053–1058 (1999)CrossRefPubMed F. Pallardo, L. Herranz, T. Garcia-Ingelmo, C. Grande, P. Martin-Vaquero, M. Jañez, A. Gonzalez, Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care 22(7), 1053–1058 (1999)CrossRefPubMed
9.
go back to reference N. Schwartz, Z. Nachum, M. S. Green, Risk factors of gestational diabetes mellitus recurrence: a meta-analysis. Endocrine 1–10 (2016). [Epub ahead of print] N. Schwartz, Z. Nachum, M. S. Green, Risk factors of gestational diabetes mellitus recurrence: a meta-analysis. Endocrine 1–10 (2016). [Epub ahead of print]
10.
go back to reference C.A. Major, M. deVeciana, J. Weeks, M.A. Morgan, Recurrence of gestational diabetes: who is at risk?. Am J Obstet Gynecol 179(4), 1038–1042 (1998)CrossRefPubMed C.A. Major, M. deVeciana, J. Weeks, M.A. Morgan, Recurrence of gestational diabetes: who is at risk?. Am J Obstet Gynecol 179(4), 1038–1042 (1998)CrossRefPubMed
11.
go back to reference T. Nohira, S. Kim, H. Nakai, K. Okabe, T. Nohira, K. Yoneyama, Recurrence of gestational diabetes mellitus: rates and risk factors from initial GDM and one abnormal GTT value. Diabetes Res Clin Pract 71(1), 75–81 (2006)CrossRefPubMed T. Nohira, S. Kim, H. Nakai, K. Okabe, T. Nohira, K. Yoneyama, Recurrence of gestational diabetes mellitus: rates and risk factors from initial GDM and one abnormal GTT value. Diabetes Res Clin Pract 71(1), 75–81 (2006)CrossRefPubMed
12.
go back to reference H.J. Holmes, J.Y. Lo, D.D. McIntire, B.M. Casey, Prediction of diabetes recurrence in women with class A1 (diet-treated) gestational diabetes. Am J Perinatol 27(1), 47–52 (2010)CrossRefPubMed H.J. Holmes, J.Y. Lo, D.D. McIntire, B.M. Casey, Prediction of diabetes recurrence in women with class A1 (diet-treated) gestational diabetes. Am J Perinatol 27(1), 47–52 (2010)CrossRefPubMed
13.
go back to reference A.Z. Khambalia, J.B. Ford, N. Nassar, A.W. Shand, A. McElduff, C.L. Roberts, Occurrence and recurrence of diabetes in pregnancy. Diabet Med J Br Diabet Assoc 30(4), 452–456 (2013)CrossRef A.Z. Khambalia, J.B. Ford, N. Nassar, A.W. Shand, A. McElduff, C.L. Roberts, Occurrence and recurrence of diabetes in pregnancy. Diabet Med J Br Diabet Assoc 30(4), 452–456 (2013)CrossRef
14.
go back to reference C.V. Ananth, Epidemiologic Approaches for Studying Recurrent Pregnancy Outcomes: Challenges and Implications for Research. Semin Perinatol 31(3), 196–201 (2007)CrossRefPubMed C.V. Ananth, Epidemiologic Approaches for Studying Recurrent Pregnancy Outcomes: Challenges and Implications for Research. Semin Perinatol 31(3), 196–201 (2007)CrossRefPubMed
15.
go back to reference S. Mizrahi, N. Cohen, Privatization Through Centralization in the Israeli Health Care System The Case of the National Health Insurance Law and its Amendments. Adm Soc 44(4), 412–437 (2012)CrossRef S. Mizrahi, N. Cohen, Privatization Through Centralization in the Israeli Health Care System The Case of the National Health Insurance Law and its Amendments. Adm Soc 44(4), 412–437 (2012)CrossRef
16.
go back to reference M.W. Carpenter, D.R. Coustan, Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144(7), 768–773 (1982)CrossRefPubMed M.W. Carpenter, D.R. Coustan, Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144(7), 768–773 (1982)CrossRefPubMed
17.
go back to reference Group NDD, Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance. Diabetes 28(12), 1039–1057 (1979)CrossRef Group NDD, Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance. Diabetes 28(12), 1039–1057 (1979)CrossRef
18.
go back to reference O. Langer, L. Brustman, A. Anyaegbunam, R. Mazze, The significance of one abnormal glucose tolerance test value on adverse outcome in pregnancy. Am J Obstet Gynecol 157(3), 758–763 (1987)CrossRefPubMed O. Langer, L. Brustman, A. Anyaegbunam, R. Mazze, The significance of one abnormal glucose tolerance test value on adverse outcome in pregnancy. Am J Obstet Gynecol 157(3), 758–763 (1987)CrossRefPubMed
19.
go back to reference O. Langer, A. Anyaegbunam, L. Brustman, M. Divon, Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy. Am J Obstet Gynecol 161(3), 593–599 (1989)CrossRefPubMed O. Langer, A. Anyaegbunam, L. Brustman, M. Divon, Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy. Am J Obstet Gynecol 161(3), 593–599 (1989)CrossRefPubMed
20.
go back to reference J.A. Deddens, M.R. Petersen, Approaches for estimating prevalence ratios. Occup Environ Med 65(7), 501–506 (2008)CrossRef J.A. Deddens, M.R. Petersen, Approaches for estimating prevalence ratios. Occup Environ Med 65(7), 501–506 (2008)CrossRef
21.
go back to reference R.K. Peters, S.L. Kjos, A. Xiang, T.A. Buchanan, Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 347(8996), 227–230 (1996)CrossRefPubMed R.K. Peters, S.L. Kjos, A. Xiang, T.A. Buchanan, Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 347(8996), 227–230 (1996)CrossRefPubMed
22.
go back to reference E.H. Philipson, D.M. Super, Gestational diabetes mellitus: does it recur in subsequent pregnancy?. Am J Obstet Gynecol 160(6), 1324–1331 (1989)CrossRefPubMed E.H. Philipson, D.M. Super, Gestational diabetes mellitus: does it recur in subsequent pregnancy?. Am J Obstet Gynecol 160(6), 1324–1331 (1989)CrossRefPubMed
23.
go back to reference D. Getahun, M.J. Fassett, S.J. Jacobsen, Gestational diabetes: risk of recurrence in subsequent pregnancies. Am J Obstet Gynecol 203(5), 467 (2010). e1-6CrossRefPubMed D. Getahun, M.J. Fassett, S.J. Jacobsen, Gestational diabetes: risk of recurrence in subsequent pregnancies. Am J Obstet Gynecol 203(5), 467 (2010). e1-6CrossRefPubMed
24.
go back to reference S.F. Ehrlich, M.M. Hedderson, J. Feng, E.R. Davenport, E.P. Gunderson, A. Ferrara, Change in body mass index between pregnancies and the risk of gestational diabetes in a second pregnancy. Obstet Gynecol 117(6), 1323–1330 (2011)CrossRefPubMedPubMedCentral S.F. Ehrlich, M.M. Hedderson, J. Feng, E.R. Davenport, E.P. Gunderson, A. Ferrara, Change in body mass index between pregnancies and the risk of gestational diabetes in a second pregnancy. Obstet Gynecol 117(6), 1323–1330 (2011)CrossRefPubMedPubMedCentral
26.
go back to reference C. Kim, D.K. Berger, S. Chamany, Recurrence of gestational diabetes mellitus: a systematic review. Diabetes Care 30(5), 1314–1319 (2007)CrossRefPubMed C. Kim, D.K. Berger, S. Chamany, Recurrence of gestational diabetes mellitus: a systematic review. Diabetes Care 30(5), 1314–1319 (2007)CrossRefPubMed
27.
go back to reference J.N. Bottalico, Recurrent Gestational Diabetes: Risk Factors, Diagnosis, Management, and Implications. Semin Perinatol 31(3), 176–184 (2007)CrossRefPubMed J.N. Bottalico, Recurrent Gestational Diabetes: Risk Factors, Diagnosis, Management, and Implications. Semin Perinatol 31(3), 176–184 (2007)CrossRefPubMed
28.
go back to reference A. Lindquist, N. Noor, E. Sullivan, M. Knight, The impact of socioeconomic position on severe maternal morbidity outcomes among women in Australia: a national case-control study. BJOG Int J Obstet Gynaecol 122(12), 1601–1609 (2014)CrossRef A. Lindquist, N. Noor, E. Sullivan, M. Knight, The impact of socioeconomic position on severe maternal morbidity outcomes among women in Australia: a national case-control study. BJOG Int J Obstet Gynaecol 122(12), 1601–1609 (2014)CrossRef
29.
go back to reference International Association of Diabetes and Pregnancy Study Groups Consensus Panel, B.E. Metzger, S.G. Gabbe, B. Persson, T.A. Buchanan, P.A. Catalano et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33, 676–682 (2010)CrossRefPubMedCentral International Association of Diabetes and Pregnancy Study Groups Consensus Panel, B.E. Metzger, S.G. Gabbe, B. Persson, T.A. Buchanan, P.A. Catalano et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33, 676–682 (2010)CrossRefPubMedCentral
30.
go back to reference D.A. Sacks, D.R. Hadden, M. Maresh, C. Deerochanawong, A.R. Dyer, B.E. Metzger et al. Frequency of Gestational Diabetes Mellitus at Collaborating Centers Based on IADPSG Consensus Panel–Recommended Criteria. Diabetes Care 35(3), 526–528 (2012)CrossRefPubMedPubMedCentral D.A. Sacks, D.R. Hadden, M. Maresh, C. Deerochanawong, A.R. Dyer, B.E. Metzger et al. Frequency of Gestational Diabetes Mellitus at Collaborating Centers Based on IADPSG Consensus Panel–Recommended Criteria. Diabetes Care 35(3), 526–528 (2012)CrossRefPubMedPubMedCentral
Metadata
Title
Modifiable risk factors for gestational diabetes recurrence
Authors
Naama Schwartz
Manfred S. Green
Enav Yefet
Zohar Nachum
Publication date
01-12-2016
Publisher
Springer US
Published in
Endocrine / Issue 3/2016
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1087-2

Other articles of this Issue 3/2016

Endocrine 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine